May 7, 2026 · Form 4 insider transaction
Sullivan Christopher Ryan bought 18,606 shares of Avalo Therapeutics, Inc. at $9.88 per share, a transaction worth $183.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.